Wouters, O. J., McKee, M. & Luyten, J. Estimated research and development investment needed to bring a new medicine to market, 2009–2018. JAMA 323, 844–853 (2020).
Varga, Z. V., Ferdinandy, P., Liaudet, L. & Pacher, P. Drug-induced mitochondrial dysfunction and cardiotoxicity. Am. J. Physiol. Heart Circ. Physiol. 309, H1453–H1467 (2015).
Bird, S. D. et al. The human adult cardiomyocyte phenotype. Cardiovasc. Res. 58, 423–434 (2003).
Milani-Nejad, N. & Janssen, P. M. L. Small and large animal models in cardiac contraction research: advantages and disadvantages. Pharmacol. Ther. 14, 235–249 (2014).
Maltsev, V. A., Rohwedel, J., Hescheler, J. & Wobus, A. M. Embryonic stem cells differentiate in vitro into cardiomyocytes representing sinusnodal, atrial and ventricular cell types. Mech. Dev. 44, 41–50 (1993).
Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861–872 (2007).
Colatsky, T. et al. The Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative — update on progress. J. Pharmacol. Toxicol. Methods 81, 15–20 (2016).
McKenna, W. J. & Judg, D. P. Epidemiology of the inherited cardiomyopathies. Nat. Rev. Cardiol. 18, 22–36 (2021).
Ho, C. Y. et al. Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe). Circulation 138, 1387–1398 (2018).
Lippi, M. et al. Spectrum of rare and common genetic variants in arrhythmogenic cardiomyopathy patients. Biomolecules 12, 1043 (2022).
Haas, J. et al. Atlas of the clinical genetics of human dilated cardiomyopathy. Eur. Heart J. 36, 1123–1135 (2015).
Bhagwan, J. R. et al. Isogenic models of hypertrophic cardiomyopathy unveil differential phenotypes and mechanism-driven therapeutics. J. Mol. Cell. Cardiol. 145, 43–53 (2020).
Mosqueira, D. et al. CRISPR/Cas9 editing in human pluripotent stemcell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy. Eur. Heart J. 39, 3879–3892 (2018).
Loiben, A. M. et al. Cardiomyocyte apoptosis is associated with contractile dysfunction in stem cell model of MYH7 E848G hypertrophic cardiomyopathy. Int. J. Mol. Sci. 24, 4909 (2023).
Prondzynski, M. et al. Disease modeling of a mutation in α‐actinin 2 guides clinical therapy in hypertrophic cardiomyopathy. EMBO Mol. Med. 11, e11115 (2019).
Zhang, K. et al. Plakophilin-2 truncating variants impair cardiac contractility by disrupting sarcomere stability and organization. Sci. Adv. 7, eabh3995 (2021).
Cohn, R. et al. A contraction stress model of hypertrophic cardiomyopathy due to sarcomere mutations. Stem Cell Reports 12, 71–83 (2019).
Hinson, J. T. et al. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy. Science 349, 982–986 (2015).
Toepfer, C. N. et al. Myosin sequestration regulates sarcomere function, cardiomyocyte energetics, and metabolism, informing the pathogenesis of hypertrophic cardiomyopathy. Circulation 141, 828–842 (2020).
Briganti, F. et al. iPSC modeling of RBM20-deficient DCM identifies upregulation of RBM20 as a therapeutic strategy. Cell Rep. 32, 108117 (2020).
Knight, W. E. et al. Maturation of pluripotent stem cell-derived cardiomyocytes enables modeling of human hypertrophic cardiomyopathy. Stem Cell Reports 16, 519–533 (2021). An informative study using a combination of metabolic maturation and micropatterned surfaces to improve the maturation of hiPSC-CMs, increasing sensitivity to pathological stimuli.
Querdel, E. et al. Human engineered heart tissue patches remuscularize the injured heart in a dose-dependent manner. Circulation 143, 1991–2006 (2021). An informative study using dynamic mechanical stimulation of EHT patches to obtain improved maturation of hiPSC-CMs. Transplantation of the patches resulted in partial remuscularization of the injured heart in a guinea pig injury model.
Liu, Y. W. et al. Human embryonic stem cell-derived cardiomyocytes restore function in infarcted hearts of non-human primates. Nat. Biotechnol. 36, 597–605 (2018).
Karbassi, E. et al. Cardiomyocyte maturation: advances in knowledge and implications for regenerative medicine. Nat. Rev. Cardiol. 17, 341–359 (2020). A comprehensive review on the structural and functional characteristics of mature CMs.
Yang, X., Pabon, L. & Murry, C. E. Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes. Circ. Res. 114, 511–523 (2014).
Feyen, D. A. M. et al. Metabolic maturation media improve physiological function of human iPSC-derived cardiomyocytes. Cell Rep. 32, 107925 (2020). An informative study using metabolic maturation techniques in 2D and 3D, obtaining improved functional maturation of hiPSC-CMs.
Tsan, Y. C. et al. Physiologic biomechanics enhance reproducible contractile development in a stem cell derived cardiac muscle platform. Nat. Commun. 12, 6167 (2021). An informative study using micropatterning on elastomer substrates to define tissue biomechanics and improve the maturation of hiPSC-CMs.
Herron, T. J. et al. Extracellular matrix-mediated maturation of human pluripotent stem cell-derived cardiac monolayer structure and electrophysiological function. Circ. Arrhythm. Electrophysiol. 9, e003638 (2016).
Martella, D. et al. Liquid crystalline networks toward regenerative medicine and tissue repair. Small 13, 1702677 (2017).
Lin, B. et al. Culture in glucose-depleted medium supplemented with fatty acid and 3,3′,5-triiodo-l-thyronine facilitates purification and maturation of human pluripotent stem cell-derived cardiomyocytes. Front. Endocrinol. 8, 253 (2017).
Miki, K. et al. ERRγ enhances cardiac maturation with t-tubule formation in human iPSC-derived cardiomyocytes. Nat. Commun. 12, 3596 (2021).
Mulieri, L. A., Hasenfuss, G., Leavitt, B., Allen, P. D. & Alpert, N. R. Altered myocardial force–frequency relation in human heart failure. Circulation 85, 1743–1750 (1992).
Melby, J. A. et al. Functionally integrated top–down proteomics for standardized assessment of human induced pluripotent stem cell-derived engineered cardiac tissues. J. Proteome Res. 20, 1424–1433 (2021). An informative study establishing a method allowing for the sequential assessment of functional properties and top–down proteomics for hiPSC-engineered cardiac tissue.
Ewoldt, J. K. and DePalma, S.J. et al. Induced pluripotent stem cell-derived cardiomyocyte in vitro models: tissue fabrication protocols, assessment methods, and quantitative maturation metrics for benchmarking progress. Dryad https://doi.org/10.5061/dryad.ksn02v7bh (2024).
Lapp, H. et al. Author Correction: Frequency-dependent drug screening using optogenetic stimulation of human iPSC-derived cardiomyocytes. Sci. Rep. 11, 1643 (2021).
Schnabel, L. V., Abratte, C. M., Schimenti, J. C., Southard, T. L. & Fortier, L. A. Genetic background affects induced pluripotent stem cell generation. Stem Cell Res. Ther. 3, 30 (2012).
Rouhani, F. et al. Genetic background drives transcriptional variation in human induced pluripotent stem cells. PLoS Genet. 10, e1004432 (2014).
Mannhardt, I. et al. Comparison of 10 control hPSC lines for drug screening in an engineered heart tissue format. Stem Cell Reports 15, 983–998 (2020). An informative study comparing ten different control hiPSC-CM lines in EHT to demonstrate large baseline cell line-dependent differences in tissue function.
Marinho, P. A., Chailangkarn, T. & Muotri, A. R. Systematic optimization of human pluripotent stem cells media using design of experiments. Sci. Rep. 5, 9834 (2015).
Block, T. et al. Human perinatal stem cell derived extracellular matrix enables rapid maturation of hiPSC-CM structural and functional phenotypes. Sci. Rep. 10, 19071 (2020).
Zhang, J. et al. Cardiac differentiation of human pluripotent stem cells using defined extracellular matrix proteins reveals essential role of fibronectin. eLife 11, e69028 (2022).
Lian, X. et al. Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc. Natl Acad. Sci. USA 109, E1848–E1857 (2012).
Mummery, C. L. et al. Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Circ. Res. 111, 344–358 (2012).
Tohyama, S. et al. Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. Cell Stem Cell 12, 127–137 (2013).
Xu, C. et al. Bioinspired onion epithelium-like structure promotes the maturation of cardiomyocytes derived from human pluripotent stem cells. Biomater. Sci. 5, 1810–1819 (2017).
Ma, Z. et al. Self-organizing human cardiac microchambers mediated by geometric confinement. Nat. Commun. 6, 7413 (2015).
Schulz, A. et al. Tyramine-conjugated alginate hydrogels as a platform for bioactive scaffolds. J. Biomed. Mater. Res. A 107, 114–121 (2019).
Hart, C. et al. Rapid nanofabrication of nanostructured interdigitated electrodes (NIDES) for long-term in vitro analysis of human induced pluripotent stem cell differentiated cardiomyocytes. Biosensors 8, 88 (2018).
Sun, S. et al. Progressive myofibril reorganization of human cardiomyocytes on a dynamic nanotopographic substrate. ACS Appl. Mater. Interfaces 12, 21450–21462 (2020).
Martewicz, S. et al. Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli. Ann. Biomed. Eng. 47, 852–865 (2019).
Kujala, V. J., Pasqualini, F. S., Goss, J. A., Nawroth, J. C. & Parker, K. K. Laminar ventricular myocardium on a microelectrode array-based chip. J. Mater. Chem. B 4, 3534–3543 (2016).
Pioner, J. M. et al. Isolation and mechanical measurements of myofibrils from human induced pluripotent stem cell-derived cardiomyocytes. Stem Cell Reports 6, 885–896 (2016).
Strimaityte, D. et al. Contractility and calcium transient maturation in the human iPSC-derived cardiac microfibers. ACS Appl. Mater. Interfaces 14, 35376–35388 (2022).
Wheelwright, M. et al. Investigation of human iPSC-derived cardiac myocyte functional maturation by single cell traction force microscopy. PLoS ONE 13, e0194909 (2018).
Kit-Anan, W. et al. Multiplexing physical stimulation on single human induced pluripotent stem cell-derived cardiomyocytes for phenotype modulation. Biofabrication 13, 025004 (2021).
Wanjare, M. et al. Anisotropic microfibrous scaffolds enhance the organization and function of cardiomyocytes derived from induced pluripotent stem cells. Biomater. Sci. 5, 1567–1578 (2017).
Kumar, N. et al. Scalable biomimetic coaxial aligned nanofiber cardiac patch: a potential model for ‘clinical trials in a dish’. Front. Bioeng. Biotechnol. 8, 567842 (2020).
Depalma, S. J., Davidson, C. D., Stis, A. E., Helms, A. S. & Baker, B. M. Microenvironmental determinants of organized iPSC-cardiomyocyte tissues on synthetic fibrous matrices. Biomater. Sci. 9, 93–107 (2021).
Li, J. et al. Extracellular recordings of patterned human pluripotent stem cell-derived cardiomyocytes on aligned fibers. Stem Cells Int. 2016, 2634013 (2016).
Chun, Y. W. et al. Combinatorial polymer matrices enhance in vitro maturation of human induced pluripotent stem cell-derived cardiomyocytes. Biomaterials 67, 52–64 (2015).
Khan, M. et al. Evaluation of changes in morphology and function of human induced pluripotent stem cell derived cardiomyocytes (hiPSC-CMs) cultured on an aligned-nanofiber cardiac patch. PLoS ONE 10, e0126338 (2015).
Pushp, P. et al. Functional comparison of beating cardiomyocytes differentiated from umbilical cord-derived mesenchymal/stromal stem cells and human foreskin-derived induced pluripotent stem cells. J. Biomed. Mater. Res. A 108, 496–514 (2020).
Chen, Y., Chan, J. P. Y., Wu, J., Li, R. K. & Santerre, J. P. Compatibility and function of human induced pluripotent stem cell derived cardiomyocytes on an electrospun nanofibrous scaffold, generated from an ionomeric polyurethane composite. J. Biomed. Mater. Res. A 110, 1932–1943 (2022).
Tang, Y. et al. Induction and differentiation of human induced pluripotent stem cells into functional cardiomyocytes on a compartmented monolayer of gelatin nanofibers. Nanoscale 8, 14530–14540 (2016).
Takada, T. et al. Aligned human induced pluripotent stem cell-derived cardiac tissue improves contractile properties through promoting unidirectional and synchronous cardiomyocyte contraction. Biomaterials 281, 121351 (2022).
Pioner, J. M. et al. Optical investigation of action potential and calcium handling maturation of hiPSC-cardiomyocytes on biomimetic substrates. Int. J. Mol. Sci. 20, 3799 (2019).
Huethorst, E. et al. Customizable, engineered substrates for rapid screening of cellular cues. Biofabrication 12, 025009 (2020).
Carson, D. et al. Nanotopography-induced structural anisotropy and sarcomere development in human cardiomyocytes derived from induced pluripotent stem cells. ACS Appl. Mater. Interfaces 8, 21923–21932 (2016).
Smith, A. S. T. et al. NanoMEA: a tool for high-throughput, electrophysiological phenotyping of patterned excitable cells. Nano Lett. 20, 1561–1570 (2020).
Afzal, J. et al. Cardiac ultrastructure inspired matrix induces advanced metabolic and functional maturation of differentiated human cardiomyocytes. Cell Rep. 40, 111146 (2022).
Cui, H. et al. 4D physiologically adaptable cardiac patch: a 4-month in vivo study for the treatment of myocardial infarction. Sci. Adv. 6, eabb5067 (2020).
Zhang, Y. S. et al. Bioprinting 3D microfibrous scaffolds for engineering endothelialized myocardium and heart-on-a-chip. Biomaterials 110, 45–59 (2016).
Gao, L. et al. Myocardial tissue engineering with cells derived from human-induced pluripotent stem cells and a native-like, high-resolution, 3-dimensionally printed scaffold. Circ. Res. 120, 1318–1325 (2017).
Feaster, T. K., Casciola, M., Narkar, A. & Blinova, K. Acute effects of cardiac contractility modulation on human induced pluripotent stem cell-derived cardiomyocytes. Physiol. Rep. 9, e15085 (2021).
Lind, J. U. et al. Instrumented cardiac microphysiological devices via multimaterial three-dimensional printing. Nat. Mater. 16, 303–308 (2017).
Jia, J. et al. Development of peptide-functionalized synthetic hydrogel microarrays for stem cell and tissue engineering applications. Acta Biomater. 45, 110–120 (2016).
Park, S. J. et al. Insights into the pathogenesis of catecholaminergic polymorphic ventricular tachycardia from engineered human heart tissue. Circulation 140, 390–404 (2019).
Parikh, S. S. et al. Thyroid and glucocorticoid hormones promote functional t-tubule development in human-induced pluripotent stem cell-derived cardiomyocytes. Circ. Res. 121, 1323–1330 (2017).
Garbern, J. C. et al. Inhibition of mTOR signaling enhances maturation of cardiomyocytes derived from human-induced pluripotent stem cells via p53-induced quiescence. Circulation 141, 285–300 (2020).
Pasqualini, F. S., Sheehy, S. P., Agarwal, A., Aratyn-Schaus, Y. & Parker, K. K. Structural phenotyping of stem cell-derived cardiomyocytes. Stem Cell Reports 4, 340–347 (2015).
Buikema, J. W. et al. Wnt activation and reduced cell–cell contact synergistically induce massive expansion of functional human iPSC-derived cardiomyocytes. Cell Stem Cell 27, 50–63 (2020).
Guo, J. et al. Elastomer-grafted iPSC-derived micro heart muscles to investigate effects of mechanical loading on physiology. ACS Biomater. Sci. Eng. 7, 2973–2989 (2021).
Dou, W. et al. A microdevice platform for characterizing the effect of mechanical strain magnitudes on the maturation of iPSC-cardiomyocytes. Biosens. Bioelectron. 175, 112875 (2021).
Kroll, K. et al. Electro-mechanical conditioning of human iPSC-derived cardiomyocytes for translational research. Prog. Biophys. Mol. Biol. 130, 212–222 (2017).
Noor, N. et al. 3D printing of personalized thick and perfusable cardiac patches and hearts. Adv. Sci. 6, 1900344 (2019).
Schwan, J. et al. Anisotropic engineered heart tissue made from laser-cut decellularized myocardium. Sci. Rep. 6, 32068 (2016).
Goldfracht, I. et al. Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications. Acta Biomater. 92, 145–159 (2019).
Blazeski, A. et al. Functional properties of engineered heart slices incorporating human induced pluripotent stem cell-derived cardiomyocytes. Stem Cell Reports 12, 982–995 (2019).
Vannozzi, L. et al. Self-folded hydrogel tubes for implantable muscular tissue scaffolds. Macromol. Biosci. 18, e1700377 (2018).
Abecasis, B. et al. Unveiling the molecular crosstalk in a human induced pluripotent stem cell-derived cardiac model. Biotechnol. Bioeng. 116, 1245–1252 (2019).
Floy, M. E. et al. Direct coculture of human pluripotent stem cell-derived cardiac progenitor cells with epicardial cells induces cardiomyocyte proliferation and reduces sarcomere organization. J. Mol. Cell. Cardiol. 162, 144–157 (2022).
Peters, M. C. et al. Follistatin-like 1 promotes proliferation of matured human hypoxic iPSC-cardiomyocytes and is secreted by cardiac fibroblasts. Mol. Ther. Methods Clin. Dev. 25, 3–16 (2022).
Hookway, T. A. et al. Phenotypic variation between stromal cells differentially impacts engineered cardiac tissue function. Tissue Eng. Part A 25, 773–785 (2019).
Rupert, C. E., Kim, T. Y., Choi, B. R. & Coulombe, K. L. K. Human cardiac fibroblast number and activation state modulate electromechanical function of hiPSC-cardiomyocytes in engineered myocardium. Stem Cells Int. 2020, 9363809 (2020).
Giacomelli, E. et al. Human-iPSC-derived cardiac stromal cells enhance maturation in 3D cardiac microtissues and reveal non-cardiomyocyte contributions to heart disease. Cell Stem Cell 26, 862–879 (2020). An informative study parsing the impact of co-culture with cardiac fibroblasts and ECs on the maturation of hiPSC-CMs in scaffold-free cardiac spheroids.
Ahrens, J. H. et al. Programming cellular alignment in engineered cardiac tissue via bioprinting anisotropic organ building blocks. Adv. Mater. 34, e2200217 (2022).
Feric, N. T. et al. Engineered cardiac tissues generated in the Biowire II: a platform for human-based drug discovery. Toxicol. Sci. 172, 89–97 (2019).
Tamargo, M. A. et al. MilliPillar: a platform for the generation and real-time assessment of human engineered cardiac tissues. ACS Biomater. Sci. Eng. 7, 5215–5229 (2021).
Ulmer, B. M. et al. Contractile work contributes to maturation of energy metabolism in hiPSC-derived cardiomyocytes. Stem Cell Reports 10, 834–847 (2018).
Boudou, T. et al. A microfabricated platform to measure and manipulate the mechanics of engineered cardiac microtissues. Tissue Eng. Part A 18, 910–919 (2012).
Lee, S. et al. Contractile force generation by 3D hiPSC-derived cardiac tissues is enhanced by rapid establishment of cellular interconnection in matrix with muscle-mimicking stiffness. Biomaterials 131, 111–120 (2017).
Feaster, T. K. et al. A method for the generation of single contracting human-induced pluripotent stem cell-derived cardiomyocytes. Circ. Res. 117, 995–1000 (2015).
Jayne, R. K. et al. Direct laser writing for cardiac tissue engineering: a microfluidic heart on a chip with integrated transducers. Lab Chip 21, 1724–1737 (2021).
Rogers, A. J., Fast, V. G. & Sethu, P. Biomimetic cardiac tissue model enables the adaption of human induced pluripotent stem cell cardiomyocytes to physiological hemodynamic loads. Anal. Chem. 88, 9862–9868 (2016).
Ng, R. et al. Contractile work directly modulates mitochondrial protein levels in human engineered heart tissues. Am. J. Physiol. Heart Circ. Physiol. 318, 1516–1524 (2020).
Ma, X. et al. 3D printed micro-scale force gauge arrays to improve human cardiac tissue maturation and enable high throughput drug testing. Acta Biomater. 95, 319–327 (2019).
Ruan, J. L. et al. Mechanical stress promotes maturation of human myocardium from pluripotent stem cell-derived progenitors. Stem Cells 33, 2148–2157 (2015).
Kolanowski, T. J. et al. Enhanced structural maturation of human induced pluripotent stem cell-derived cardiomyocytes under a controlled microenvironment in a microfluidic system. Acta Biomater. 102, 273–286 (2020).
Marsano, A. et al. Beating heart on a chip: a novel microfluidic platform to generate functional 3D cardiac microtissues. Lab Chip 16, 599–610 (2016).
Gao, L. et al. Large cardiac muscle patches engineered from human induced-pluripotent stem cell-derived cardiac cells improve recovery from myocardial infarction in swine. Circulation 137, 1712–1730 (2018).
Ribeiro, A. J. S. et al. Contractility of single cardiomyocytes differentiated from pluripotent stem cells depends on physiological shape and substrate stiffness. Proc. Natl Acad. Sci. USA 112, 12705–12710 (2015).
Abilez, O. J. et al. Passive stretch induces structural and functional maturation of engineered heart muscle as predicted by computational modeling. Stem Cells 36, 265–277 (2018).
Leonard, A. et al. Afterload promotes maturation of human induced pluripotent stem cell derived cardiomyocytes in engineered heart tissues. J. Mol. Cell. Cardiol. 118, 147–158 (2018).
Bliley, J. M. et al. Dynamic loading of human engineered heart tissue enhances contractile function and drives a desmosome-linked disease phenotype. Sci. Transl. Med. 13, 1817 (2021).
Ruan, J. L. et al. Mechanical stress conditioning and electrical stimulation promote contractility and force maturation of induced pluripotent stem cell-derived human cardiac tissue. Circulation 134, 1557–1567 (2016).
Ronaldson-Bouchard, K. et al. Advanced maturation of human cardiac tissue grown from pluripotent stem cells. Nature 556, 239–243 (2018). An informative study demonstrating the effectiveness of electromechanical training for the maturation of hiPSC-CMs.
Yoshida, S. et al. Maturation of human induced pluripotent stem cell-derived cardiomyocytes by soluble factors from human mesenchymal stem cells. Mol. Ther. 26, 2681–2695 (2018).
Yang, X. et al. Tri-iodo-l-thyronine promotes the maturation of human cardiomyocytes-derived from induced pluripotent stem cells. J. Mol. Cell. Cardiol. 72, 296–304 (2014).
Correia, C. et al. Distinct carbon sources affect structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. Sci. Rep. 7, 8590 (2017). An informative study demonstrating the link between metabolic substrate utilization and functional maturation of hiPSC-CMs.
Zhao, B., Zhang, K., Chen, C. S. & Lejeune, E. Sarc-Graph: automated segmentation, tracking, and analysis of sarcomeres in hiPSC-derived cardiomyocytes. PLoS Comput. Biol. 17, e1009443 (2021).
Toepfer, C. N. et al. SarcTrack. Circ. Res. 124, 1172–1183 (2019).
Morrill, E. E. et al. A validated software application to measure fiber organization in soft tissue. Biomech. Model. Mechanobiol. 15, 1467–1478 (2016).
Stein, J. M. et al. Software tool for automatic quantification of sarcomere length and organization in fixed and live 2D and 3D muscle cell cultures in vitro. Curr. Protoc. 2, e462 (2022).
Sutcliffe, M. D. et al. High content analysis identifies unique morphological features of reprogrammed cardiomyocytes. Sci. Rep. 8, 1258 (2018).
Mills, R. J. et al. Functional screening in human cardiac organoids reveals a metabolic mechanism for cardiomyocyte cell cycle arrest. Proc. Natl Acad. Sci. USA 114, E8372–E8381 (2017).
Fukushima, H. et al. Specific induction and long-term maintenance of high purity ventricular cardiomyocytes from human induced pluripotent stem cells. PLoS ONE 15, e0241287 (2020).
Garay, B. I. et al. Dual inhibition of MAPK and PI3K/AKT pathways enhances maturation of human iPSC-derived cardiomyocytes. Stem Cell Reports 17, 2005–2022 (2022).
Ergir, E. et al. Generation and maturation of human iPSC-derived 3D organotypic cardiac microtissues in long-term culture. Sci. Rep. 12, 17409 (2022).
Cui, N. et al. Doxorubicin-induced cardiotoxicity is maturation dependent due to the shift from topoisomerase IIα to IIβ in human stem cell derived cardiomyocytes. J. Cell. Mol. Med. 23, 4627–4639 (2019).
Jabbour, R. J. et al. In vivo grafting of large engineered heart tissue patches for cardiac repair. JCI Insight 6, e144068 (2021).
Hatani, T. et al. Nano-structural analysis of engrafted human induced pluripotent stem cell-derived cardiomyocytes in mouse hearts using a genetic-probe APEX2. Biochem. Biophys. Res. Commun. 505, 1251–1256 (2018).
Kerscher, P. et al. Direct hydrogel encapsulation of pluripotent stem cells enables ontomimetic differentiation and growth of engineered human heart tissues. Biomaterials 83, 383–395 (2016).
Huang, C. Y. et al. Enhancement of human iPSC-derived cardiomyocyte maturation by chemical conditioning in a 3D environment. J. Mol. Cell. Cardiol. 138, 1–11 (2020).
Mannhardt, I. et al. Human engineered heart tissue: analysis of contractile force. Stem Cell Reports 7, 29–42 (2016).
Shadrin, I. Y. et al. Cardiopatch platform enables maturation and scale-up of human pluripotent stem cell-derived engineered heart tissues. Nat. Commun. 8, 1825 (2017).
Huebsch, N. et al. Automated video-based analysis of contractility and calcium flux in human-induced pluripotent stem cell-derived cardiomyocytes cultured over different spatial scales. Tissue Eng. Part C Methods 21, 467–479 (2015).
Sharma, A., Toepfer, C. N., Schmid, M., Garfinkel, A. C. & Seidman, C. E. Differentiation and contractile analysis of GFP-sarcomere reporter hiPSC-cardiomyocytes. Curr. Protoc. Hum. Genet. 96, 21.12.1–21.12.12 (2018).
Maddah, M. et al. A non-invasive platform for functional characterization of stem-cell-derived cardiomyocytes with applications in cardiotoxicity testing. Stem Cell Reports 4, 621–631 (2015).
Psaras, Y. et al. CalTrack: high-throughput automated calcium transient analysis in cardiomyocytes. Circ. Res. 129, 326–341 (2021).
Yang, H. et al. Deriving waveform parameters from calcium transients in human iPSC-derived cardiomyocytes to predict cardiac activity with machine learning. Stem Cell Reports 17, 556–568 (2022).
Shroff, S. N. et al. Voltage imaging of cardiac cells and tissue using the genetically encoded voltage sensor archon1. iScience 23, 100974 (2020).
Lopaschuk, G. D., Spafford, M. A. & Marsh Cardiovascular, D. R. Glycolysis is predominant source of myocardial ATP production immediately after birth. Am. J. Physiol. 216, 1698–1705 (1991).
Murashige, D. et al. Comprehensive quantification of fuel use by the failing and nonfailing human heart. Science 370, 364–368 (2020).
Bhute, V. J. et al. Metabolomics identifies metabolic markers of maturation in human pluripotent stem cell-derived cardiomyocytes. Theranostics 7, 2078–2091 (2017).
Yang, X. et al. Fatty acids enhance the maturation of cardiomyocytes derived from human pluripotent stem cells. Stem Cell Reports 13, 657–668 (2019).
Horikoshi, Y. et al. Fatty acid-treated induced pluripotent stem cell-derived human cardiomyocytes exhibit adult cardiomyocyte-like energy metabolism phenotypes. Cells 8, 1095 (2019).
Zhang, J. Z. et al. A human iPSC double-reporter system enables purification of cardiac lineage subpopulations with distinct function and drug response profiles. Cell Stem Cell 24, 802–811 (2019).
Da Rocha, A. M. et al. hiPSC-CM monolayer maturation state determines drug responsiveness in high throughput pro-arrhythmia screen. Sci. Rep. 7, 13834 (2017).
Huebsch, N. et al. Metabolically driven maturation of human-induced-pluripotent-stem-cell-derived cardiac microtissues on microfluidic chips. Nat. Biomed. Eng. 6, 372–388 (2022). An informative study using microfluidic chips and metabolic maturation to improve the alignment and maturation of hiPSC-CMs.
Lemcke, H., Skorska, A., Lang, C. I., Johann, L. & David, R. Quantitative evaluation of the sarcomere network of human hiPSC-derived cardiomyocytes using single-molecule localization microscopy. Int. J. Mol. Sci. 21, 2819 (2020).
Yang, B. et al. A net mold-based method of biomaterial-free three-dimensional cardiac tissue creation. Tissue Eng. Part C Methods 25, 243–252 (2019).
Piccini, I., Rao, J., Seebohm, G. & Greber, B. Human pluripotent stem cell-derived cardiomyocytes: genome-wide expression profiling of long-term in vitro maturation in comparison to human heart tissue. Genom. Data 4, 69–72 (2015).
Tsui, J. H. et al. Tunable electroconductive decellularized extracellular matrix hydrogels for engineering human cardiac microphysiological systems. Biomaterials 272, 120764 (2021).
Guyette, J. P. et al. Bioengineering human myocardium on native extracellular matrix. Circ. Res. 118, 56–72 (2016).
Zhao, Y. et al. A platform for generation of chamber-specific cardiac tissues and disease modeling. Cell 176, 913–927 (2019).
Pretorius, D. et al. Layer-by-layer fabrication of large and thick human cardiac muscle patch constructs with superior electrophysiological properties. Front. Cell Dev. Biol. 9, 670504 (2021).
Geng, L. et al. Rapid electrical stimulation increased cardiac apoptosis through disturbance of calcium homeostasis and mitochondrial dysfunction in human induced pluripotent stem cell-derived cardiomyocytes. Cell. Physiol. Biochem. 47, 1167–1180 (2018).
Dickerson, D. A. Advancing engineered heart muscle tissue complexity with hydrogel composites. Adv. Biol. 7, e2200067 (2023).
Tani, H. et al. Heart-derived collagen promotes maturation of engineered heart tissue. Biomaterials 299, 122174 (2023).
Kaiser, N. J., Kant, R. J., Minor, A. J. & Coulombe, K. L. K. Optimizing blended collagen–fibrin hydrogels for cardiac tissue engineering with human iPSC-derived cardiomyocytes. ACS Biomater. Sci. Eng. 5, 887–899 (2019).
Lv, W., Babu, A., Morley, M. P., Musunuru, K. & Guerraty, M. Resource of gene expression data from a multiethnic population cohort of induced pluripotent cell-derived cardiomyocytes. Circ. Genom. Precis. Med. 17, e004218 (2024).
Soepriatna, A. H. et al. Action potential metrics and automated data analysis pipeline for cardiotoxicity testing using optically mapped hiPSC-derived 3D cardiac microtissues. PLoS ONE 18, e0280406 (2023).
Olivetti, G. et al. Aging, cardiac hypertrophy and ischemic cardiomyopathy do not affect the proportion of mononucleated and multinucleated myocytes in the human heart. J. Mol. Cell. Cardiol. 28, 1463–1477 (1996).
Squire, J. M. Architecture and function in the muscle sarcomere. Curr. Opin. Struct. Biol. 7, 247–257 (1997).
Martin Gerdes, A. et al. Structural remodeling of cardiac myocytes in patients with ischemic cardiomyopathy. Circulation 86, 426–430 (1992).
Feric, N. T. & Radisic, M. Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues. Adv. Drug Deliv. Rev. 96, 110–134 (2016).
Porter, G. A. et al. Bioenergetics, mitochondria, and cardiac myocyte differentiation. Prog. Pediatr. Cardiol. 31, 75–81 (2011).
Nagueh, S. F. et al. Altered titin expression, myocardial stiffness, and left ventricular function in patients with dilated cardiomyopathy. Circulation 110, 155–162 (2004).
Van Der Velden, J. et al. Isometric tension development and its calcium sensitivity in skinned myocyte-sized preparations from different regions of the human heart. Cardiovasc. Res. 42, 706–719 (1999).
Hasenfuss, G. et al. Energetics of isometric force development in control and volume-overload human myocardium comparison with animal species. Circ. Res. 68, 836–846 (1990).
Tenreiro, M. F., Louro, A. F., Alves, P. M. & Serra, M. Next generation of heart regenerative therapies: progress and promise of cardiac tissue engineering. NPJ Regen. Med. 6, 30 (2021).
Drouin, E., Charpentier, F., Gauthier, C., Laurent, K. & Le Marec, H. Electrophysiologic characteristics of cells spanning the left ventricular wall of human heart: evidence for presence of M cells. J. Am. Coll. Cardiol. 26, 185–192 (1995).
Koncz, I. et al. Electrophysiological effects of ivabradine in dog and human cardiac preparations: potential antiarrhythmic actions. Eur. J. Pharmacol. 668, 419–426 (2011).
Dangman, K. H. et al. Electrophysiologic characteristics of human ventricular and Purkinje fibers. Circulation 65, 362–368 (1982).
Carafoli, E., Santella, L., Branca, D. & Brini, M. Generation, control, and processing of cellular calcium signals. Crit. Rev. Biochem. Mol. Biol. 36, 107–260 (2001).
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.nature.com/articles/s41592-024-02480-7